Today in Australian law

Parliament and regulators

NSW medicines framework takes effect

The replacement Act and Regulation distinguish notification from prior approval in the state's Opioid Treatment Program.

New South WalesEvent:

Where it standsThe Medicines, Poisons and Therapeutic Goods Act 2022 and its 2026 Regulation commenced on 5 November 2026.

What happened

NSW replaced its 1966 Act and 2008 Regulation. One practical difference for compliance teams is the approval pathway in the Opioid Treatment Program: a prescriber must notify NSW Health before starting standard treatment and obtain its approval before using a non-standard medicine or dose.

Why it matters

A notification receipt is not an approval. Health-sector clients need procedures that distinguish those two steps.

What a firm does with this

In NSW compliance checklists, identify which pathway applies and what record demonstrates that the required step occurred.

Read the source

General information, not legal advice. A summary is not the judgment, bill or release: read the source before you rely on it.